Motif ID: Elf1_Elf2_Etv2_Elf4
Z-value: 3.010
Transcription factors associated with Elf1_Elf2_Etv2_Elf4:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Elf1 | ENSMUSG00000036461.9 | Elf1 |
| Elf2 | ENSMUSG00000037174.12 | Elf2 |
| Elf4 | ENSMUSG00000031103.6 | Elf4 |
| Etv2 | ENSMUSG00000006311.8 | Etv2 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Elf1 | mm10_v2_chr14_+_79515618_79515694 | 0.40 | 2.8e-04 | Click! |
| Elf2 | mm10_v2_chr3_-_51277470_51277514 | 0.31 | 5.5e-03 | Click! |
| Elf4 | mm10_v2_chrX_-_48454152_48454193 | -0.26 | 2.3e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.1 | 48.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 10.7 | 32.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 10.1 | 40.4 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 10.1 | 30.2 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 9.9 | 29.8 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 7.4 | 29.5 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 7.3 | 29.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 7.1 | 21.4 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
| 6.7 | 20.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 6.3 | 31.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 6.1 | 36.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 5.9 | 23.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 5.6 | 56.1 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 5.4 | 21.5 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 5.3 | 32.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
| 5.3 | 31.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 5.2 | 20.8 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 5.2 | 36.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 5.1 | 20.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 5.1 | 25.4 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 5.0 | 20.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 4.8 | 33.8 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 4.8 | 14.4 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 4.8 | 4.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 4.7 | 23.7 | GO:1990839 | response to endothelin(GO:1990839) |
| 4.7 | 42.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 4.4 | 13.3 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
| 4.4 | 13.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 4.3 | 17.3 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 4.1 | 12.4 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 4.1 | 12.4 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 4.0 | 28.3 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 4.0 | 12.1 | GO:1990046 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 4.0 | 16.0 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
| 3.8 | 3.8 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 3.8 | 18.9 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 3.7 | 22.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 3.6 | 7.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 3.6 | 21.6 | GO:0046070 | dGTP metabolic process(GO:0046070) |
| 3.6 | 10.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 3.6 | 10.7 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
| 3.6 | 60.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 3.5 | 3.5 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 3.5 | 34.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 3.4 | 13.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 3.4 | 10.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 3.4 | 17.0 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 3.3 | 19.8 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 3.3 | 26.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 3.3 | 9.9 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 3.3 | 6.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 3.2 | 3.2 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) protein localization to chromatin(GO:0071168) |
| 3.2 | 28.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 3.1 | 9.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 3.1 | 15.7 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 3.1 | 21.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 3.1 | 3.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 3.1 | 9.2 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 3.1 | 43.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 3.1 | 9.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 3.1 | 18.4 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 3.1 | 30.7 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 3.1 | 9.2 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 3.0 | 27.1 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 3.0 | 11.9 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 3.0 | 8.9 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 2.9 | 2.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 2.9 | 14.5 | GO:0061511 | centriole elongation(GO:0061511) |
| 2.9 | 20.3 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 2.9 | 8.6 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 2.8 | 2.8 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 2.8 | 19.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 2.8 | 8.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 2.8 | 11.0 | GO:0030576 | Cajal body organization(GO:0030576) |
| 2.7 | 8.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 2.7 | 8.1 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 2.7 | 80.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 2.6 | 7.9 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
| 2.6 | 15.6 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 2.6 | 7.8 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 2.6 | 10.4 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 2.6 | 7.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 2.6 | 15.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 2.6 | 23.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 2.6 | 5.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 2.5 | 7.5 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 2.5 | 7.5 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 2.5 | 7.5 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 2.5 | 12.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 2.5 | 2.5 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
| 2.5 | 17.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 2.5 | 9.8 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 2.4 | 2.4 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 2.4 | 2.4 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 2.4 | 9.5 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 2.4 | 7.1 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 2.4 | 4.7 | GO:0000237 | leptotene(GO:0000237) |
| 2.3 | 2.3 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 2.3 | 6.9 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 2.3 | 6.9 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 2.3 | 9.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 2.3 | 6.8 | GO:0035878 | nail development(GO:0035878) |
| 2.3 | 9.0 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 2.3 | 13.5 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 2.2 | 4.5 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 2.2 | 28.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 2.2 | 2.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 2.2 | 24.3 | GO:0060539 | diaphragm development(GO:0060539) |
| 2.2 | 8.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 2.2 | 15.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 2.2 | 19.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 2.2 | 2.2 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 2.2 | 4.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 2.2 | 10.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 2.1 | 12.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 2.1 | 17.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 2.1 | 4.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 2.1 | 6.3 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 2.1 | 4.2 | GO:0014891 | striated muscle atrophy(GO:0014891) |
| 2.1 | 6.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 2.1 | 8.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 2.1 | 14.6 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
| 2.1 | 6.2 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
| 2.1 | 8.3 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 2.1 | 2.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 2.1 | 4.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 2.1 | 6.2 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
| 2.0 | 12.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 2.0 | 6.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 2.0 | 6.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 2.0 | 10.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 2.0 | 4.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
| 2.0 | 6.0 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 2.0 | 7.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 2.0 | 7.9 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
| 2.0 | 5.9 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 2.0 | 15.6 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 2.0 | 11.7 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 1.9 | 7.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 1.9 | 31.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 1.9 | 17.5 | GO:0001842 | neural fold formation(GO:0001842) |
| 1.9 | 17.4 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 1.9 | 5.8 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
| 1.9 | 3.8 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 1.9 | 7.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.9 | 23.0 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 1.9 | 21.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 1.9 | 7.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 1.9 | 11.4 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 1.9 | 13.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 1.9 | 14.8 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 1.9 | 7.4 | GO:0015889 | cobalamin transport(GO:0015889) |
| 1.8 | 11.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 1.8 | 16.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 1.8 | 5.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 1.8 | 1.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 1.8 | 11.0 | GO:0044351 | macropinocytosis(GO:0044351) |
| 1.8 | 7.3 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 1.8 | 1.8 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 1.8 | 5.5 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.8 | 40.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 1.8 | 3.6 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 1.8 | 5.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 1.8 | 7.2 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 1.8 | 9.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 1.8 | 5.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 1.8 | 3.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 1.8 | 5.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
| 1.8 | 16.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 1.8 | 5.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 1.8 | 37.5 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
| 1.8 | 1.8 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 1.8 | 7.1 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
| 1.8 | 5.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 1.8 | 30.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 1.8 | 7.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 1.8 | 5.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 1.8 | 5.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 1.7 | 5.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 1.7 | 22.5 | GO:0001675 | acrosome assembly(GO:0001675) |
| 1.7 | 50.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 1.7 | 3.4 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) cellular response to camptothecin(GO:0072757) |
| 1.7 | 5.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 1.7 | 18.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 1.7 | 5.1 | GO:0061010 | gall bladder development(GO:0061010) |
| 1.7 | 25.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 1.7 | 10.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 1.7 | 10.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 1.7 | 1.7 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 1.7 | 5.0 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 1.6 | 4.9 | GO:0008050 | female courtship behavior(GO:0008050) |
| 1.6 | 3.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 1.6 | 6.4 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
| 1.6 | 1.6 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 1.6 | 1.6 | GO:1905075 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 1.6 | 9.4 | GO:0003383 | apical constriction(GO:0003383) |
| 1.6 | 7.8 | GO:1903232 | melanosome assembly(GO:1903232) |
| 1.5 | 13.9 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 1.5 | 7.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
| 1.5 | 3.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
| 1.5 | 4.6 | GO:1902071 | positive regulation of cellular response to hypoxia(GO:1900039) regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 1.5 | 4.6 | GO:0021998 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) regulation of cardiac ventricle development(GO:1904412) positive regulation of cardiac ventricle development(GO:1904414) |
| 1.5 | 38.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 1.5 | 7.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 1.5 | 15.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 1.5 | 35.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 1.5 | 8.9 | GO:0015074 | DNA integration(GO:0015074) |
| 1.5 | 1.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 1.5 | 4.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.5 | 5.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 1.5 | 26.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 1.5 | 4.4 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 1.4 | 10.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 1.4 | 11.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 1.4 | 7.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 1.4 | 2.8 | GO:0051026 | chiasma assembly(GO:0051026) |
| 1.4 | 11.4 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
| 1.4 | 4.2 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 1.4 | 31.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 1.4 | 4.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 1.4 | 7.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 1.4 | 26.8 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
| 1.4 | 11.2 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 1.4 | 8.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 1.4 | 1.4 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 1.4 | 4.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
| 1.4 | 5.5 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 1.4 | 5.5 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 1.4 | 2.7 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 1.4 | 1.4 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
| 1.4 | 9.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 1.4 | 2.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 1.4 | 17.6 | GO:0051451 | myoblast migration(GO:0051451) |
| 1.3 | 2.7 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
| 1.3 | 20.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 1.3 | 2.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 1.3 | 14.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 1.3 | 4.0 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 1.3 | 25.2 | GO:0016180 | snRNA processing(GO:0016180) |
| 1.3 | 5.3 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 1.3 | 9.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 1.3 | 5.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 1.3 | 3.9 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 1.3 | 1.3 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 1.3 | 15.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 1.3 | 2.6 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
| 1.3 | 12.9 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
| 1.3 | 2.6 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
| 1.3 | 5.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 1.3 | 3.8 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 1.3 | 5.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 1.3 | 6.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 1.3 | 6.3 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 1.3 | 3.8 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 1.3 | 3.8 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 1.3 | 2.5 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
| 1.2 | 5.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 1.2 | 3.7 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.2 | 3.7 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
| 1.2 | 2.5 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
| 1.2 | 3.7 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 1.2 | 3.7 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 1.2 | 11.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 1.2 | 2.5 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.2 | 12.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 1.2 | 9.8 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 1.2 | 8.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 1.2 | 4.9 | GO:0070269 | pyroptosis(GO:0070269) |
| 1.2 | 25.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 1.2 | 9.7 | GO:0051298 | centrosome duplication(GO:0051298) |
| 1.2 | 2.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 1.2 | 9.7 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 1.2 | 4.8 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
| 1.2 | 2.4 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 1.2 | 4.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
| 1.2 | 4.8 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
| 1.2 | 9.5 | GO:0036506 | maintenance of unfolded protein(GO:0036506) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 1.2 | 3.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 1.2 | 4.7 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 1.2 | 4.6 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 1.2 | 2.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 1.2 | 3.5 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 1.2 | 46.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
| 1.2 | 1.2 | GO:0016925 | protein sumoylation(GO:0016925) |
| 1.2 | 3.5 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 1.1 | 5.7 | GO:0051697 | protein delipidation(GO:0051697) |
| 1.1 | 6.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 1.1 | 13.7 | GO:0030539 | male genitalia development(GO:0030539) |
| 1.1 | 4.5 | GO:0080144 | amino acid homeostasis(GO:0080144) |
| 1.1 | 4.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 1.1 | 6.8 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 1.1 | 5.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 1.1 | 2.2 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 1.1 | 3.4 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 1.1 | 3.3 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 1.1 | 4.4 | GO:0048793 | pronephros development(GO:0048793) |
| 1.1 | 3.3 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 1.1 | 1.1 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 1.1 | 1.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 1.1 | 2.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 1.1 | 48.2 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 1.1 | 2.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 1.1 | 4.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 1.1 | 6.6 | GO:0051657 | maintenance of organelle location(GO:0051657) |
| 1.1 | 2.2 | GO:1903011 | negative regulation of bone development(GO:1903011) |
| 1.1 | 1.1 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
| 1.1 | 18.4 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 1.1 | 2.2 | GO:1905076 | regulation of interleukin-17 secretion(GO:1905076) negative regulation of interleukin-17 secretion(GO:1905077) |
| 1.1 | 6.5 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 1.1 | 10.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
| 1.1 | 1.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 1.1 | 2.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 1.1 | 5.3 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 1.1 | 1.1 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
| 1.1 | 5.3 | GO:0032329 | serine transport(GO:0032329) |
| 1.1 | 17.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 1.0 | 2.1 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 1.0 | 1.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 1.0 | 1.0 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 1.0 | 4.2 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 1.0 | 25.0 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
| 1.0 | 3.1 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 1.0 | 4.2 | GO:1902430 | neuronal signal transduction(GO:0023041) negative regulation of beta-amyloid formation(GO:1902430) |
| 1.0 | 3.1 | GO:0006968 | cellular defense response(GO:0006968) |
| 1.0 | 2.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 1.0 | 5.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 1.0 | 3.1 | GO:0007144 | female meiosis I(GO:0007144) |
| 1.0 | 1.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 1.0 | 5.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
| 1.0 | 8.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 1.0 | 1.0 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
| 1.0 | 2.0 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
| 1.0 | 5.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 1.0 | 5.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 1.0 | 5.0 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 1.0 | 13.9 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 1.0 | 38.1 | GO:0006284 | base-excision repair(GO:0006284) |
| 1.0 | 10.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 1.0 | 2.9 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 1.0 | 4.9 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 1.0 | 3.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 1.0 | 4.8 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 1.0 | 3.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.0 | 2.9 | GO:0048478 | replication fork protection(GO:0048478) |
| 1.0 | 1.0 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
| 1.0 | 3.8 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
| 1.0 | 2.9 | GO:0032532 | regulation of microvillus length(GO:0032532) |
| 1.0 | 4.8 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
| 1.0 | 2.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.9 | 2.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.9 | 16.0 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.9 | 4.7 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
| 0.9 | 2.8 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.9 | 7.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.9 | 4.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.9 | 0.9 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
| 0.9 | 10.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.9 | 2.8 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.9 | 1.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.9 | 0.9 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.9 | 1.8 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.9 | 3.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.9 | 2.7 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.9 | 16.4 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.9 | 0.9 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.9 | 2.7 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.9 | 9.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.9 | 11.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.9 | 3.6 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.9 | 7.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.9 | 2.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.9 | 2.7 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.9 | 8.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.9 | 2.7 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
| 0.9 | 2.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.9 | 2.7 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.9 | 12.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.9 | 2.6 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
| 0.9 | 0.9 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
| 0.9 | 2.6 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.9 | 2.6 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.9 | 1.7 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.9 | 0.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.9 | 3.4 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.9 | 6.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.9 | 2.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.9 | 3.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.9 | 19.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.9 | 2.6 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
| 0.9 | 3.4 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.8 | 0.8 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.8 | 1.7 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 0.8 | 2.5 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.8 | 23.5 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.8 | 5.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.8 | 2.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
| 0.8 | 3.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.8 | 2.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.8 | 30.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.8 | 2.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.8 | 1.7 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.8 | 10.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.8 | 15.6 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.8 | 4.9 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.8 | 5.7 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.8 | 4.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.8 | 5.6 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.8 | 0.8 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.8 | 1.6 | GO:0021915 | neural tube development(GO:0021915) |
| 0.8 | 10.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.8 | 13.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.8 | 2.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.8 | 1.6 | GO:1902524 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.8 | 1.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.8 | 3.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.8 | 12.6 | GO:0000303 | response to superoxide(GO:0000303) |
| 0.8 | 0.8 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
| 0.8 | 6.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.8 | 1.6 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.8 | 11.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.8 | 4.7 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.8 | 3.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.8 | 3.9 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.8 | 3.9 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.8 | 6.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.8 | 3.1 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.8 | 1.5 | GO:1903204 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.8 | 3.8 | GO:0015867 | ATP transport(GO:0015867) |
| 0.8 | 5.3 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.8 | 1.5 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.8 | 9.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.8 | 4.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.8 | 6.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.8 | 1.5 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.8 | 4.5 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.7 | 3.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.7 | 7.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
| 0.7 | 0.7 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.7 | 2.2 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.7 | 0.7 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
| 0.7 | 3.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.7 | 4.4 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.7 | 8.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.7 | 3.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.7 | 6.6 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 0.7 | 3.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.7 | 2.2 | GO:1902946 | protein localization to early endosome(GO:1902946) |
| 0.7 | 2.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.7 | 2.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.7 | 6.4 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.7 | 7.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.7 | 4.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.7 | 0.7 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.7 | 4.9 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.7 | 2.1 | GO:0090370 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) negative regulation of cholesterol efflux(GO:0090370) |
| 0.7 | 3.5 | GO:0048241 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.7 | 0.7 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.7 | 7.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.7 | 6.2 | GO:0006560 | proline metabolic process(GO:0006560) |
| 0.7 | 0.7 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.7 | 16.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.7 | 2.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.7 | 8.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.7 | 2.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.7 | 2.7 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.7 | 2.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
| 0.7 | 2.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.7 | 3.3 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.7 | 2.0 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.7 | 1.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.7 | 5.3 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.7 | 35.1 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.7 | 1.3 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.7 | 4.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.7 | 1.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.7 | 4.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.7 | 0.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.6 | 2.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.6 | 0.6 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.6 | 3.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.6 | 3.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.6 | 28.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.6 | 1.9 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.6 | 2.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.6 | 1.3 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
| 0.6 | 0.6 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.6 | 5.6 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.6 | 6.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.6 | 1.9 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.6 | 0.6 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.6 | 5.6 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 0.6 | 0.6 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.6 | 1.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.6 | 0.6 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.6 | 11.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
| 0.6 | 4.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.6 | 0.6 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.6 | 1.2 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.6 | 0.6 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.6 | 28.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.6 | 3.0 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.6 | 1.2 | GO:0009838 | abscission(GO:0009838) |
| 0.6 | 3.6 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.6 | 2.4 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.6 | 1.8 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.6 | 0.6 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.6 | 1.8 | GO:0042637 | catagen(GO:0042637) |
| 0.6 | 3.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.6 | 8.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.6 | 0.6 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.6 | 1.2 | GO:0045350 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) |
| 0.6 | 2.4 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.6 | 2.4 | GO:1902741 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.6 | 1.8 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.6 | 2.3 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.6 | 4.7 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.6 | 2.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.6 | 1.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
| 0.6 | 2.9 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.6 | 0.6 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 | 6.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.6 | 1.2 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
| 0.6 | 1.7 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.6 | 2.9 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
| 0.6 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.6 | 0.6 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.6 | 1.7 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.6 | 3.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.6 | 1.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.6 | 1.1 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.6 | 8.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.6 | 1.7 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.6 | 3.3 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.6 | 0.6 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.5 | 1.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.5 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.5 | 2.7 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.5 | 3.3 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.5 | 1.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.5 | 8.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.5 | 4.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.5 | 0.5 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.5 | 9.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.5 | 1.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.5 | 4.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.5 | 2.6 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.5 | 1.6 | GO:0014044 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.5 | 1.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.5 | 2.1 | GO:0030091 | protein repair(GO:0030091) |
| 0.5 | 13.6 | GO:0006513 | protein monoubiquitination(GO:0006513) |
| 0.5 | 0.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.5 | 24.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.5 | 1.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.5 | 3.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.5 | 4.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.5 | 1.0 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
| 0.5 | 1.5 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.5 | 2.6 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.5 | 1.0 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.5 | 0.5 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
| 0.5 | 5.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.5 | 2.0 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.5 | 4.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.5 | 7.0 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.5 | 4.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.5 | 4.5 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.5 | 6.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.5 | 4.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.5 | 1.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.5 | 3.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.5 | 2.0 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.5 | 2.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.5 | 1.0 | GO:0030224 | monocyte differentiation(GO:0030224) |
| 0.5 | 0.5 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.5 | 6.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.5 | 1.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.5 | 7.8 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.5 | 1.5 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.5 | 0.5 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.5 | 1.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.5 | 2.9 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.5 | 2.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.5 | 2.4 | GO:0051099 | positive regulation of binding(GO:0051099) |
| 0.5 | 2.9 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 0.5 | 4.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.5 | 0.5 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.5 | 2.4 | GO:0071320 | cellular response to cAMP(GO:0071320) |
| 0.5 | 1.9 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.5 | 1.9 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.5 | 7.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.5 | 3.3 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.5 | 5.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.5 | 0.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.5 | 0.9 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.5 | 1.9 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
| 0.5 | 1.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.5 | 2.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.5 | 1.4 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.5 | 18.3 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.5 | 0.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.5 | 3.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.5 | 1.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.5 | 2.3 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.4 | 3.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.4 | 1.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.4 | 1.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.4 | 1.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.4 | 0.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.4 | 6.3 | GO:0006801 | superoxide metabolic process(GO:0006801) |
| 0.4 | 4.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.4 | 3.1 | GO:0010458 | exit from mitosis(GO:0010458) |
| 0.4 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.4 | 2.6 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.4 | 2.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.4 | 2.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.4 | 1.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.4 | 3.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.4 | 0.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.4 | 1.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.4 | 4.7 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.4 | 2.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.4 | 124.8 | GO:0008380 | RNA splicing(GO:0008380) |
| 0.4 | 1.3 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.4 | 4.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.4 | 3.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.4 | 7.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.4 | 5.5 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
| 0.4 | 1.7 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
| 0.4 | 4.6 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.4 | 3.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.4 | 0.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.4 | 4.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.4 | 3.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.4 | 2.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.4 | 0.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.4 | 4.5 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.4 | 9.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.4 | 2.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.4 | 3.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.4 | 0.8 | GO:1903416 | response to glycoside(GO:1903416) |
| 0.4 | 0.4 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.4 | 0.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.4 | 2.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.4 | 1.2 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.4 | 2.0 | GO:0045911 | positive regulation of isotype switching(GO:0045830) positive regulation of DNA recombination(GO:0045911) |
| 0.4 | 1.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.4 | 2.4 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
| 0.4 | 3.2 | GO:0048864 | stem cell development(GO:0048864) |
| 0.4 | 2.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.4 | 2.0 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
| 0.4 | 1.6 | GO:0015786 | UDP-glucose transport(GO:0015786) |
| 0.4 | 1.6 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.4 | 5.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.4 | 5.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.4 | 8.1 | GO:0006323 | DNA packaging(GO:0006323) |
| 0.4 | 1.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 | 1.9 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.4 | 3.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.4 | 2.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.4 | 3.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.4 | 3.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.4 | 0.8 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.4 | 1.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.4 | 3.8 | GO:0019243 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.4 | 2.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.4 | 3.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.4 | 1.5 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.4 | 0.7 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.4 | 4.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.4 | 1.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.4 | 3.7 | GO:0014823 | response to activity(GO:0014823) |
| 0.4 | 1.1 | GO:0007320 | insemination(GO:0007320) |
| 0.4 | 1.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
| 0.4 | 1.8 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.4 | 0.4 | GO:0070171 | negative regulation of odontogenesis(GO:0042483) negative regulation of tooth mineralization(GO:0070171) |
| 0.4 | 14.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.4 | 2.6 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.4 | 0.7 | GO:0070488 | neutrophil aggregation(GO:0070488) |
| 0.4 | 1.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.4 | 2.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
| 0.4 | 2.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.4 | 2.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.4 | 0.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.4 | 2.1 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.4 | 1.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.4 | 3.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.3 | 2.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.3 | 10.1 | GO:0048538 | thymus development(GO:0048538) |
| 0.3 | 12.4 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.3 | 10.0 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.3 | 1.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.3 | 0.3 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) |
| 0.3 | 1.0 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.3 | 0.7 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.3 | 4.8 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.3 | 0.7 | GO:0042701 | progesterone secretion(GO:0042701) |
| 0.3 | 11.9 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.3 | 1.4 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.3 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.3 | 1.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.3 | 1.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.3 | 13.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.3 | 1.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.3 | 0.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.3 | 0.7 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.3 | 2.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 | 1.0 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.3 | 2.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.3 | 12.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.3 | 2.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.3 | 9.7 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.3 | 11.3 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
| 0.3 | 30.4 | GO:0007059 | chromosome segregation(GO:0007059) |
| 0.3 | 1.9 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.3 | 2.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.3 | 0.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.3 | 26.6 | GO:0007050 | cell cycle arrest(GO:0007050) |
| 0.3 | 3.8 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.3 | 1.2 | GO:0060687 | branching involved in prostate gland morphogenesis(GO:0060442) regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 0.3 | 0.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.3 | 1.2 | GO:0000050 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.3 | 0.3 | GO:1901563 | response to camptothecin(GO:1901563) |
| 0.3 | 0.6 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
| 0.3 | 6.5 | GO:0009409 | response to cold(GO:0009409) |
| 0.3 | 6.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.3 | 1.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.3 | 1.2 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.3 | 0.3 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.3 | 0.9 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.3 | 1.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.3 | 1.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 | 1.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.3 | 1.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.3 | 7.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.3 | 2.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.3 | 2.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.3 | 8.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 | 0.6 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
| 0.3 | 1.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.3 | 1.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 | 0.6 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.3 | 0.6 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.3 | 0.3 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.3 | 0.6 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.3 | 3.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.3 | 4.0 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.3 | 5.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.3 | 3.1 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.3 | 1.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.3 | 0.8 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.3 | 0.8 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.3 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.3 | 1.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.3 | 4.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.3 | 1.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.3 | 1.6 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.3 | 15.3 | GO:0006413 | translational initiation(GO:0006413) |
| 0.3 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 | 0.8 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.3 | 0.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) sensory perception of bitter taste(GO:0050913) |
| 0.3 | 1.1 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.3 | 0.3 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.3 | 1.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.3 | 0.5 | GO:1990000 | amyloid fibril formation(GO:1990000) |
| 0.3 | 0.8 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.3 | 0.3 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.3 | 0.8 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.3 | 1.6 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.3 | 0.8 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.3 | 6.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.3 | 0.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.3 | 3.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.3 | 1.3 | GO:0090148 | membrane fission(GO:0090148) |
| 0.3 | 1.3 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
| 0.3 | 1.0 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.3 | 1.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.3 | 1.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.3 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.3 | 1.0 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.3 | 0.8 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) regulation of defense response to fungus(GO:1900150) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
| 0.3 | 0.5 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.3 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
| 0.3 | 2.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.3 | 1.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.3 | 3.0 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.3 | 1.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.3 | 0.5 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 0.2 | 0.7 | GO:0006534 | cysteine metabolic process(GO:0006534) |
| 0.2 | 3.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.2 | 0.7 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 | 1.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.2 | 1.0 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 1.0 | GO:0080111 | DNA demethylation(GO:0080111) |
| 0.2 | 1.7 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
| 0.2 | 2.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.2 | 2.2 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.2 | 0.2 | GO:2000277 | ADP transport(GO:0015866) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
| 0.2 | 1.2 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.2 | 0.9 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
| 0.2 | 2.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 | 0.9 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.2 | 2.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.2 | 3.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.2 | 0.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.2 | 0.5 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.2 | 4.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.2 | 1.1 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.2 | 8.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.2 | 0.7 | GO:0042832 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.2 | 0.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.2 | 0.9 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.2 | 0.6 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.2 | 1.5 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.2 | 1.3 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.2 | 2.4 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.2 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.2 | 2.1 | GO:0061180 | mammary gland epithelium development(GO:0061180) |
| 0.2 | 0.2 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.2 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 | 4.7 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.2 | 1.3 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
| 0.2 | 0.6 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.2 | 9.9 | GO:0001843 | neural tube closure(GO:0001843) |
| 0.2 | 5.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.2 | 3.7 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
| 0.2 | 2.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.2 | 1.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.2 | 0.8 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
| 0.2 | 2.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.2 | 4.5 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.2 | 0.8 | GO:0009301 | snRNA transcription(GO:0009301) |
| 0.2 | 1.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.2 | 0.8 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.2 | 4.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.2 | 1.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 0.2 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.2 | 0.6 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
| 0.2 | 0.6 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
| 0.2 | 1.0 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 | 1.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 | 4.2 | GO:0007588 | excretion(GO:0007588) |
| 0.2 | 1.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.2 | 5.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 | 1.5 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
| 0.2 | 0.8 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.2 | 6.1 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.2 | 1.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 0.2 | 3.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.2 | 5.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.2 | 0.9 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 | 0.5 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.2 | 4.7 | GO:0007098 | centrosome cycle(GO:0007098) |
| 0.2 | 1.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 | 0.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.2 | 0.7 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.2 | 1.8 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
| 0.2 | 0.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.2 | 0.4 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
| 0.2 | 1.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.2 | 0.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 | 0.2 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) regulation of antigen processing and presentation of peptide antigen(GO:0002583) regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
| 0.2 | 1.0 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.2 | 1.6 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.2 | 0.3 | GO:0001736 | establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) |
| 0.2 | 0.5 | GO:0045628 | T-helper 2 cell differentiation(GO:0045064) regulation of T-helper 2 cell differentiation(GO:0045628) |
| 0.2 | 0.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.2 | 0.5 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.2 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.2 | 4.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.2 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 | 5.2 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.2 | 0.7 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.2 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.2 | 0.8 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.2 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
| 0.2 | 0.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 | 7.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.2 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.2 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 | 0.3 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.2 | 1.9 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.2 | 0.5 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.2 | 0.5 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 | 0.6 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.2 | 3.2 | GO:1903008 | organelle disassembly(GO:1903008) |
| 0.2 | 1.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 | 4.4 | GO:0045861 | negative regulation of proteolysis(GO:0045861) |
| 0.2 | 0.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.2 | 1.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.2 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.2 | 0.3 | GO:0045837 | negative regulation of mitochondrial membrane potential(GO:0010917) negative regulation of membrane potential(GO:0045837) |
| 0.2 | 0.8 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.2 | 0.3 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.2 | 1.5 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
| 0.2 | 2.9 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.2 | 1.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.2 | 0.3 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.2 | 0.5 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.2 | 1.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.1 | 1.3 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
| 0.1 | 1.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 0.4 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.1 | 2.6 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
| 0.1 | 0.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 1.7 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.1 | 0.6 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
| 0.1 | 1.3 | GO:0051782 | negative regulation of cell division(GO:0051782) |
| 0.1 | 0.8 | GO:0045333 | cellular respiration(GO:0045333) |
| 0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 6.9 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.1 | 1.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
| 0.1 | 1.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 0.3 | GO:0014063 | regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
| 0.1 | 0.3 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.1 | 1.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
| 0.1 | 0.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 | 2.1 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 3.9 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 | 0.8 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
| 0.1 | 1.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.5 | GO:0038202 | TORC1 signaling(GO:0038202) |
| 0.1 | 1.8 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
| 0.1 | 0.9 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 0.7 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.1 | 1.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 0.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 | 0.6 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 0.6 | GO:1903961 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.1 | 0.1 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
| 0.1 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 0.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 1.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.1 | 0.9 | GO:0019076 | viral release from host cell(GO:0019076) regulation of viral release from host cell(GO:1902186) |
| 0.1 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 0.6 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.1 | 1.4 | GO:0001823 | ureteric bud development(GO:0001657) mesonephros development(GO:0001823) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
| 0.1 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.1 | 2.3 | GO:0007569 | cell aging(GO:0007569) |
| 0.1 | 0.4 | GO:0017145 | stem cell division(GO:0017145) |
| 0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 | 1.9 | GO:0060323 | head morphogenesis(GO:0060323) |
| 0.1 | 4.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.1 | 0.1 | GO:0060264 | respiratory burst involved in inflammatory response(GO:0002536) respiratory burst involved in defense response(GO:0002679) regulation of respiratory burst involved in inflammatory response(GO:0060264) positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.1 | 0.2 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.1 | 0.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 1.3 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
| 0.1 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 0.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 0.4 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.1 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 | 0.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.1 | 2.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 | 4.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.1 | 0.6 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.1 | 0.3 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
| 0.1 | 0.3 | GO:0019405 | alditol catabolic process(GO:0019405) |
| 0.1 | 0.4 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 | 3.8 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 | 1.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.1 | 0.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 | 0.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
| 0.1 | 0.2 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
| 0.1 | 0.6 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.1 | 1.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 | 2.9 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
| 0.1 | 0.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 | 1.5 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
| 0.1 | 0.5 | GO:0055088 | lipid homeostasis(GO:0055088) |
| 0.1 | 0.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.1 | 0.2 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) regulation of transcription by glucose(GO:0046015) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 | 0.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.1 | 0.3 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
| 0.1 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.1 | 0.2 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.1 | 0.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 0.1 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.1 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 0.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
| 0.1 | 0.3 | GO:0015793 | renal water transport(GO:0003097) glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
| 0.1 | 0.1 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.1 | 0.3 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.1 | 0.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 | 0.8 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.1 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.1 | 0.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.1 | 0.8 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 | 0.3 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
| 0.1 | 0.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 | 0.1 | GO:0019395 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
| 0.1 | 0.6 | GO:0015698 | inorganic anion transport(GO:0015698) |
| 0.1 | 0.8 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
| 0.1 | 0.4 | GO:1901989 | positive regulation of cell cycle phase transition(GO:1901989) |
| 0.1 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 2.1 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.1 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.1 | 0.2 | GO:0070723 | response to cholesterol(GO:0070723) |
| 0.1 | 0.2 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 | 0.2 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 | 0.9 | GO:0015992 | proton transport(GO:0015992) |
| 0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.3 | GO:0071472 | cellular response to salt stress(GO:0071472) |
| 0.1 | 0.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 | 0.7 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.0 | 0.3 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.0 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.0 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
| 0.0 | 0.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.0 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 | 0.1 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
| 0.0 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
| 0.0 | 0.0 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.0 | 0.0 | GO:0043631 | RNA polyadenylation(GO:0043631) |
| 0.0 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.0 | 0.2 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.0 | 0.2 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
| 0.0 | 0.1 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 | 0.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 | 0.3 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
| 0.0 | 0.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
| 0.0 | 0.2 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.0 | 0.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.0 | 0.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.0 | 0.6 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.0 | 0.1 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
| 0.0 | 0.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.0 | 0.2 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 | 0.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.0 | 0.1 | GO:0070633 | transepithelial transport(GO:0070633) |
| 0.0 | 0.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 | 2.0 | GO:0006821 | chloride transport(GO:0006821) |
| 0.0 | 0.5 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.0 | 0.5 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
| 0.0 | 0.4 | GO:0071772 | response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
| 0.0 | 0.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 | 0.2 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
| 0.0 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
| 0.0 | 0.2 | GO:0015675 | nickel cation transport(GO:0015675) |
| 0.0 | 0.3 | GO:0001541 | ovarian follicle development(GO:0001541) |
| 0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.0 | 0.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.0 | 0.3 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 0.3 | GO:0016331 | morphogenesis of embryonic epithelium(GO:0016331) |
| 0.0 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.0 | 0.0 | GO:0015817 | histidine transport(GO:0015817) |
| 0.0 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.0 | 0.1 | GO:0010470 | regulation of gastrulation(GO:0010470) |
| 0.0 | 0.5 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.0 | 0.3 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
| 0.0 | 0.0 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.0 | 0.1 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.0 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
| 0.0 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
| 0.0 | 0.1 | GO:0002063 | chondrocyte development(GO:0002063) |
| 0.0 | 0.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.0 | 0.4 | GO:0007601 | visual perception(GO:0007601) |
| 0.0 | 0.2 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 0.0 | 0.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.1 | 30.2 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 9.6 | 28.7 | GO:0071953 | elastic fiber(GO:0071953) |
| 7.1 | 21.3 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 6.1 | 30.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 6.0 | 18.0 | GO:0000801 | central element(GO:0000801) |
| 5.4 | 26.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 5.1 | 15.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
| 5.0 | 40.0 | GO:0005818 | aster(GO:0005818) |
| 4.7 | 23.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 4.5 | 13.6 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 4.5 | 13.6 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 4.2 | 21.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 3.7 | 14.9 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 3.6 | 14.5 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 3.6 | 10.7 | GO:0071914 | prominosome(GO:0071914) |
| 3.5 | 13.9 | GO:0060187 | cell pole(GO:0060187) |
| 3.5 | 20.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 3.4 | 13.8 | GO:0008623 | CHRAC(GO:0008623) |
| 3.4 | 23.7 | GO:0008278 | cohesin complex(GO:0008278) |
| 3.4 | 16.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 3.3 | 26.5 | GO:0072687 | meiotic spindle(GO:0072687) |
| 3.2 | 19.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 3.1 | 22.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 3.1 | 52.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 2.8 | 22.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 2.8 | 13.9 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 2.7 | 8.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 2.7 | 5.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 2.7 | 24.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 2.6 | 61.8 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 2.6 | 23.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 2.6 | 25.7 | GO:0090543 | Flemming body(GO:0090543) |
| 2.3 | 6.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 2.3 | 27.4 | GO:0005687 | U4 snRNP(GO:0005687) |
| 2.3 | 6.8 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 2.2 | 4.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 2.2 | 8.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 2.2 | 15.3 | GO:0000796 | condensin complex(GO:0000796) |
| 2.1 | 121.0 | GO:0005871 | kinesin complex(GO:0005871) |
| 2.1 | 14.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 2.1 | 8.4 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 2.1 | 2.1 | GO:0035101 | FACT complex(GO:0035101) |
| 2.1 | 18.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 2.1 | 8.3 | GO:0035339 | SPOTS complex(GO:0035339) |
| 2.0 | 6.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 2.0 | 21.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 1.9 | 7.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 1.9 | 7.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 1.9 | 15.1 | GO:0097342 | ripoptosome(GO:0097342) |
| 1.9 | 28.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 1.9 | 11.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 1.8 | 29.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 1.8 | 5.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 1.8 | 10.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 1.7 | 5.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 1.7 | 8.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 1.7 | 6.9 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 1.7 | 1.7 | GO:0070552 | BRISC complex(GO:0070552) |
| 1.7 | 10.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 1.7 | 6.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 1.7 | 16.7 | GO:0001739 | sex chromatin(GO:0001739) |
| 1.7 | 16.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 1.7 | 10.0 | GO:0000125 | PCAF complex(GO:0000125) |
| 1.6 | 9.6 | GO:0098536 | deuterosome(GO:0098536) |
| 1.6 | 6.3 | GO:0032021 | NELF complex(GO:0032021) |
| 1.5 | 38.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 1.5 | 22.4 | GO:0031011 | Ino80 complex(GO:0031011) |
| 1.5 | 4.5 | GO:1990423 | RZZ complex(GO:1990423) |
| 1.5 | 10.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 1.5 | 1.5 | GO:0043219 | lateral loop(GO:0043219) |
| 1.5 | 5.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 1.5 | 11.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 1.4 | 4.2 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
| 1.4 | 9.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 1.4 | 9.8 | GO:0070187 | telosome(GO:0070187) |
| 1.4 | 15.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 1.4 | 12.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 1.4 | 4.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 1.4 | 9.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 1.3 | 7.9 | GO:0071817 | MMXD complex(GO:0071817) |
| 1.3 | 10.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 1.3 | 3.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 1.3 | 6.5 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 1.3 | 6.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 1.3 | 5.1 | GO:0061702 | inflammasome complex(GO:0061702) |
| 1.3 | 3.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 1.3 | 25.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 1.3 | 20.2 | GO:0032039 | integrator complex(GO:0032039) |
| 1.3 | 7.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 1.2 | 64.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 1.2 | 3.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 1.2 | 3.6 | GO:0031417 | NatC complex(GO:0031417) |
| 1.2 | 1.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 1.2 | 6.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 1.1 | 11.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 1.1 | 18.0 | GO:0030008 | TRAPP complex(GO:0030008) |
| 1.1 | 3.4 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
| 1.1 | 16.7 | GO:0070938 | contractile ring(GO:0070938) |
| 1.1 | 6.7 | GO:0030914 | STAGA complex(GO:0030914) |
| 1.1 | 3.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 1.1 | 16.6 | GO:0005682 | U5 snRNP(GO:0005682) |
| 1.1 | 17.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 1.1 | 13.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 1.1 | 16.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 1.0 | 6.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 1.0 | 3.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 1.0 | 7.3 | GO:0097452 | GAIT complex(GO:0097452) |
| 1.0 | 6.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 1.0 | 2.1 | GO:0033010 | paranodal junction(GO:0033010) |
| 1.0 | 8.2 | GO:0033269 | internode region of axon(GO:0033269) |
| 1.0 | 7.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 1.0 | 8.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 1.0 | 2.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 1.0 | 9.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 1.0 | 11.8 | GO:0005686 | U2 snRNP(GO:0005686) |
| 1.0 | 7.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 1.0 | 2.0 | GO:0000812 | Swr1 complex(GO:0000812) |
| 1.0 | 5.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 1.0 | 10.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 1.0 | 14.5 | GO:0051286 | cell tip(GO:0051286) |
| 1.0 | 28.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.9 | 9.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.9 | 8.5 | GO:0030478 | actin cap(GO:0030478) |
| 0.9 | 12.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.9 | 13.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.9 | 12.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.9 | 7.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.9 | 2.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
| 0.9 | 0.9 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.9 | 7.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.9 | 20.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.9 | 8.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.9 | 22.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.9 | 2.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.9 | 3.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.9 | 6.9 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.9 | 6.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.8 | 3.4 | GO:0043259 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) |
| 0.8 | 7.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.8 | 11.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.8 | 2.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.8 | 5.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.8 | 2.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.8 | 6.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
| 0.8 | 11.3 | GO:0042555 | MCM complex(GO:0042555) |
| 0.8 | 13.7 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.8 | 3.2 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.8 | 6.3 | GO:0045095 | keratin filament(GO:0045095) |
| 0.8 | 5.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 0.8 | 8.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.8 | 7.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.8 | 0.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.8 | 7.0 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.8 | 33.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.8 | 24.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.8 | 12.2 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.7 | 4.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.7 | 2.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.7 | 2.2 | GO:1990047 | spindle matrix(GO:1990047) |
| 0.7 | 44.0 | GO:0016459 | myosin complex(GO:0016459) |
| 0.7 | 2.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.7 | 7.4 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.7 | 3.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.7 | 66.9 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.7 | 1.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.7 | 3.7 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.7 | 2.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.7 | 2.2 | GO:0036125 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
| 0.7 | 6.5 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.7 | 1.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.7 | 60.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.7 | 5.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.7 | 2.8 | GO:0090537 | CERF complex(GO:0090537) |
| 0.7 | 1.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.7 | 6.9 | GO:0016589 | NURF complex(GO:0016589) |
| 0.7 | 2.0 | GO:0031251 | PAN complex(GO:0031251) |
| 0.7 | 5.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.7 | 2.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.7 | 0.7 | GO:0033202 | DNA helicase complex(GO:0033202) |
| 0.7 | 8.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.7 | 5.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.7 | 2.0 | GO:0001652 | granular component(GO:0001652) |
| 0.7 | 7.2 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.6 | 3.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.6 | 1.3 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.6 | 9.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.6 | 1.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.6 | 5.8 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
| 0.6 | 31.7 | GO:0000922 | spindle pole(GO:0000922) |
| 0.6 | 2.5 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.6 | 6.3 | GO:0000800 | lateral element(GO:0000800) |
| 0.6 | 2.5 | GO:0071942 | XPC complex(GO:0071942) |
| 0.6 | 80.1 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.6 | 3.1 | GO:0031523 | Myb complex(GO:0031523) |
| 0.6 | 3.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.6 | 4.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.6 | 3.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.6 | 6.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.6 | 0.6 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.6 | 17.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.6 | 1.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.6 | 6.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
| 0.6 | 11.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.6 | 44.8 | GO:0005814 | centriole(GO:0005814) |
| 0.6 | 3.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.6 | 6.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.6 | 2.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.6 | 4.0 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.6 | 3.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.6 | 3.4 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.6 | 6.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.6 | 15.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.6 | 12.2 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.6 | 7.7 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
| 0.5 | 1.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.5 | 4.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.5 | 3.2 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.5 | 1.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.5 | 2.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.5 | 3.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.5 | 1.6 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.5 | 10.0 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.5 | 1.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.5 | 16.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.5 | 49.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.5 | 4.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.5 | 14.6 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
| 0.5 | 10.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.5 | 4.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.5 | 2.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.5 | 23.1 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.5 | 2.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.5 | 6.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.5 | 31.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.5 | 6.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.5 | 4.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.5 | 1.4 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.5 | 27.8 | GO:0005811 | lipid particle(GO:0005811) |
| 0.5 | 3.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.5 | 4.1 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.4 | 1.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.4 | 1.3 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.4 | 6.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.4 | 5.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.4 | 2.6 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.4 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.4 | 3.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.4 | 4.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.4 | 4.2 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.4 | 4.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.4 | 0.8 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.4 | 16.7 | GO:0005657 | replication fork(GO:0005657) |
| 0.4 | 2.8 | GO:0071203 | WASH complex(GO:0071203) |
| 0.4 | 1.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.4 | 2.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.4 | 3.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.4 | 20.5 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.4 | 6.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.4 | 0.8 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
| 0.4 | 0.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.4 | 14.7 | GO:0005844 | polysome(GO:0005844) |
| 0.4 | 0.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.4 | 1.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.4 | 1.1 | GO:0045179 | apical cortex(GO:0045179) |
| 0.4 | 1.9 | GO:0034448 | EGO complex(GO:0034448) |
| 0.4 | 1.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.4 | 0.7 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
| 0.4 | 25.7 | GO:0000776 | kinetochore(GO:0000776) |
| 0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.4 | 0.7 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.4 | 1.8 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
| 0.4 | 2.9 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.4 | 5.0 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.4 | 1.1 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.3 | 11.9 | GO:0000786 | nucleosome(GO:0000786) |
| 0.3 | 2.1 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.3 | 2.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.3 | 5.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.3 | 1.7 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.3 | 1.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.3 | 80.5 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.3 | 30.3 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.3 | 2.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.3 | 3.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.3 | 6.8 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.3 | 18.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.3 | 1.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.3 | 1.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.3 | 5.7 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.3 | 0.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.3 | 1.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.3 | 1.2 | GO:0005694 | chromosome(GO:0005694) |
| 0.3 | 1.2 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.3 | 23.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.3 | 12.4 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.3 | 1.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
| 0.3 | 16.4 | GO:0005902 | microvillus(GO:0005902) |
| 0.3 | 0.6 | GO:0010369 | chromocenter(GO:0010369) |
| 0.3 | 90.3 | GO:0005813 | centrosome(GO:0005813) |
| 0.3 | 18.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.3 | 1.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.3 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.3 | 8.3 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.3 | 1.1 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.3 | 3.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.3 | 0.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.3 | 2.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.3 | 15.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.3 | 0.8 | GO:0098830 | presynaptic endosome(GO:0098830) |
| 0.3 | 25.9 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.3 | 15.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.3 | 1.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.3 | 3.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.2 | 8.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.2 | 0.7 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.2 | 2.5 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.2 | 7.3 | GO:0044391 | ribosomal subunit(GO:0044391) |
| 0.2 | 7.0 | GO:0016592 | mediator complex(GO:0016592) |
| 0.2 | 5.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.2 | 2.8 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.2 | 3.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.2 | 11.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.2 | 8.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.2 | 4.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 0.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 3.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.2 | 12.8 | GO:0001726 | ruffle(GO:0001726) |
| 0.2 | 2.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.2 | 1.5 | GO:0031415 | NatA complex(GO:0031415) |
| 0.2 | 340.1 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.2 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.2 | 6.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.2 | 0.4 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.2 | 20.0 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.2 | 1.9 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 0.2 | 5.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.2 | 2.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.2 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.2 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.2 | 1.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.2 | 1.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.1 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 415.2 | GO:0005634 | nucleus(GO:0005634) |
| 0.1 | 0.8 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
| 0.1 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.1 | 0.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 0.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.1 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.1 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.1 | 0.4 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.1 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 0.1 | GO:0097361 | CIA complex(GO:0097361) |
| 0.1 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.0 | 0.0 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.0 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.0 | 1.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
| 0.0 | 0.1 | GO:0045180 | basal cortex(GO:0045180) |
| 0.0 | 0.2 | GO:0030673 | axolemma(GO:0030673) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.3 | 37.0 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 7.5 | 44.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 7.0 | 21.1 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 5.5 | 16.5 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
| 5.3 | 26.7 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 5.3 | 16.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 5.2 | 20.8 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 4.9 | 19.5 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 4.5 | 22.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 4.4 | 13.3 | GO:0004335 | galactokinase activity(GO:0004335) |
| 4.4 | 17.6 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 4.4 | 35.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 4.3 | 21.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 4.3 | 21.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 4.2 | 58.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 4.0 | 12.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 4.0 | 12.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 3.9 | 11.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 3.8 | 15.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 3.7 | 29.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 3.7 | 11.1 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 3.7 | 11.0 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
| 3.7 | 40.4 | GO:0070990 | snRNP binding(GO:0070990) |
| 3.6 | 7.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 3.6 | 17.9 | GO:0043515 | kinetochore binding(GO:0043515) |
| 3.5 | 13.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 3.4 | 13.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 3.4 | 13.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 3.3 | 33.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 3.3 | 3.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
| 3.3 | 9.9 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 3.1 | 33.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 3.0 | 9.0 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 3.0 | 17.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 3.0 | 8.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 2.9 | 14.7 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 2.9 | 14.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 2.7 | 11.0 | GO:1990254 | keratin filament binding(GO:1990254) |
| 2.6 | 5.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 2.5 | 7.5 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 2.5 | 7.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 2.4 | 7.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 2.4 | 29.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 2.4 | 19.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 2.4 | 9.6 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 2.4 | 11.9 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 2.4 | 14.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 2.4 | 9.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 2.3 | 18.8 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 2.3 | 9.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 2.3 | 7.0 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
| 2.3 | 7.0 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 2.3 | 32.2 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 2.3 | 2.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 2.3 | 6.9 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 2.3 | 6.9 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 2.3 | 6.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 2.3 | 9.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 2.3 | 6.8 | GO:0032564 | dATP binding(GO:0032564) |
| 2.1 | 10.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 2.1 | 6.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 2.1 | 8.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 2.1 | 2.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 2.1 | 20.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 2.0 | 6.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 2.0 | 6.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 2.0 | 8.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 2.0 | 14.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 2.0 | 6.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 2.0 | 14.1 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 2.0 | 28.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 2.0 | 12.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 1.9 | 7.6 | GO:0042806 | fucose binding(GO:0042806) |
| 1.9 | 7.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.9 | 5.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 1.9 | 5.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 1.9 | 5.6 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
| 1.8 | 16.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 1.7 | 10.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 1.7 | 7.0 | GO:0050632 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
| 1.7 | 6.9 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 1.7 | 13.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 1.7 | 15.2 | GO:0035173 | histone kinase activity(GO:0035173) |
| 1.7 | 5.0 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
| 1.7 | 16.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 1.6 | 6.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 1.6 | 13.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 1.6 | 6.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 1.5 | 16.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 1.5 | 18.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 1.5 | 20.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 1.5 | 4.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
| 1.5 | 2.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 1.4 | 4.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 1.4 | 11.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 1.4 | 9.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 1.4 | 5.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 1.4 | 8.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 1.4 | 17.7 | GO:0044548 | S100 protein binding(GO:0044548) |
| 1.4 | 4.1 | GO:0051870 | methotrexate binding(GO:0051870) |
| 1.4 | 13.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 1.3 | 4.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 1.3 | 8.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 1.3 | 5.3 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
| 1.3 | 34.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 1.3 | 5.3 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 1.3 | 2.6 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 1.3 | 91.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 1.3 | 5.2 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
| 1.3 | 3.8 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 1.3 | 3.8 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 1.3 | 13.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 1.3 | 57.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 1.3 | 7.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 1.2 | 13.7 | GO:0008430 | selenium binding(GO:0008430) |
| 1.2 | 5.0 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 1.2 | 2.5 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 1.2 | 5.0 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 1.2 | 6.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 1.2 | 3.7 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 1.2 | 4.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 1.2 | 3.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 1.2 | 5.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 1.2 | 8.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 1.2 | 2.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 1.2 | 7.0 | GO:0089720 | caspase binding(GO:0089720) |
| 1.2 | 7.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 1.2 | 10.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 1.2 | 29.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 1.2 | 5.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 1.2 | 3.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 1.2 | 8.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 1.1 | 6.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 1.1 | 9.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 1.1 | 3.4 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 1.1 | 3.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 1.1 | 11.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 1.1 | 1.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 1.1 | 14.7 | GO:0031386 | protein tag(GO:0031386) |
| 1.1 | 2.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 1.1 | 15.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 1.1 | 4.3 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
| 1.1 | 5.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 1.1 | 5.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.1 | 8.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 1.1 | 6.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 1.1 | 11.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 1.1 | 7.4 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 1.1 | 2.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 1.1 | 3.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 1.1 | 1.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 1.0 | 2.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 1.0 | 2.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 1.0 | 2.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 1.0 | 4.2 | GO:0030911 | TPR domain binding(GO:0030911) |
| 1.0 | 6.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 1.0 | 9.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) collagen receptor activity(GO:0038064) |
| 1.0 | 11.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 1.0 | 2.1 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 1.0 | 6.2 | GO:0008494 | translation activator activity(GO:0008494) |
| 1.0 | 6.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 1.0 | 2.1 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 1.0 | 8.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 1.0 | 2.0 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
| 1.0 | 3.1 | GO:0005118 | sevenless binding(GO:0005118) |
| 1.0 | 5.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 1.0 | 7.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 1.0 | 3.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 1.0 | 2.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 1.0 | 2.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 1.0 | 4.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 1.0 | 3.8 | GO:0004064 | arylesterase activity(GO:0004064) |
| 1.0 | 2.9 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 1.0 | 42.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 1.0 | 4.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.9 | 7.6 | GO:0046790 | virion binding(GO:0046790) |
| 0.9 | 5.7 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 0.9 | 4.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.9 | 8.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.9 | 15.6 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.9 | 2.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.9 | 3.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.9 | 13.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.9 | 2.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.9 | 4.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.9 | 7.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.9 | 9.0 | GO:0015217 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
| 0.9 | 22.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.9 | 34.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.9 | 2.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.9 | 3.5 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.9 | 1.7 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.9 | 18.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.9 | 6.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.9 | 2.6 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.9 | 14.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.9 | 23.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.8 | 22.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.8 | 6.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.8 | 8.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.8 | 3.4 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
| 0.8 | 3.4 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.8 | 6.7 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
| 0.8 | 4.2 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.8 | 1.7 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.8 | 10.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.8 | 7.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.8 | 3.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.8 | 2.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.8 | 75.7 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.8 | 12.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.8 | 4.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.8 | 7.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.8 | 2.4 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.8 | 36.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.8 | 2.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.8 | 129.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.8 | 5.4 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.8 | 13.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.8 | 6.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.8 | 23.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.7 | 3.0 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.7 | 6.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.7 | 1.5 | GO:0008311 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.7 | 4.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.7 | 22.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.7 | 0.7 | GO:0030519 | snoRNP binding(GO:0030519) |
| 0.7 | 4.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.7 | 6.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.7 | 1.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.7 | 3.6 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
| 0.7 | 2.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
| 0.7 | 2.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.7 | 2.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
| 0.7 | 211.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.7 | 2.1 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
| 0.7 | 2.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.7 | 9.7 | GO:0048038 | quinone binding(GO:0048038) |
| 0.7 | 3.5 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.7 | 2.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.7 | 3.4 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 0.7 | 8.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.7 | 8.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.7 | 9.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.7 | 1.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.7 | 2.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.7 | 1.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.7 | 2.6 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.6 | 1.9 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.6 | 18.1 | GO:0043531 | ADP binding(GO:0043531) |
| 0.6 | 6.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.6 | 1.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.6 | 1.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.6 | 3.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.6 | 12.1 | GO:0070888 | E-box binding(GO:0070888) |
| 0.6 | 2.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.6 | 3.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.6 | 3.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.6 | 6.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.6 | 6.9 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.6 | 2.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.6 | 3.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.6 | 2.5 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
| 0.6 | 16.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.6 | 5.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.6 | 3.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.6 | 1.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.6 | 4.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.6 | 2.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.6 | 1.8 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.6 | 1.2 | GO:0043426 | MRF binding(GO:0043426) |
| 0.6 | 3.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.6 | 3.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.6 | 1.8 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.6 | 6.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.6 | 1.8 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.6 | 6.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.6 | 10.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.6 | 11.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.6 | 1.2 | GO:0070905 | serine binding(GO:0070905) |
| 0.6 | 1.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.6 | 36.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.6 | 8.3 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.6 | 11.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.6 | 16.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.6 | 1.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.6 | 2.4 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.6 | 1.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.6 | 0.6 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 0.6 | 2.9 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.6 | 2.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.6 | 21.6 | GO:0004386 | helicase activity(GO:0004386) |
| 0.6 | 9.3 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.6 | 7.0 | GO:0005522 | profilin binding(GO:0005522) |
| 0.6 | 21.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.6 | 2.3 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
| 0.6 | 1.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.6 | 10.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.6 | 7.4 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.6 | 9.7 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.6 | 1.7 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.6 | 1.7 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.6 | 6.2 | GO:0046977 | TAP binding(GO:0046977) |
| 0.6 | 3.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.6 | 3.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.6 | 2.8 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.6 | 1.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.6 | 1.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.6 | 33.0 | GO:0002039 | p53 binding(GO:0002039) |
| 0.6 | 23.1 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.5 | 12.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.5 | 3.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.5 | 0.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.5 | 1.6 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.5 | 2.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.5 | 22.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.5 | 1.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.5 | 0.5 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.5 | 36.3 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.5 | 4.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.5 | 4.7 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.5 | 1.0 | GO:0016635 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.5 | 6.2 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
| 0.5 | 2.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.5 | 3.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.5 | 1.5 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.5 | 1.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.5 | 6.4 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.5 | 4.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.5 | 2.4 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.5 | 3.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.5 | 4.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.5 | 10.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.5 | 3.8 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.5 | 1.9 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.5 | 1.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.5 | 2.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.5 | 3.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.5 | 4.6 | GO:0017022 | myosin binding(GO:0017022) |
| 0.5 | 22.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.5 | 4.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.5 | 1.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.4 | 27.6 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.4 | 19.9 | GO:0003774 | motor activity(GO:0003774) |
| 0.4 | 1.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.4 | 1.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.4 | 1.7 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.4 | 2.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.4 | 1.3 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.4 | 0.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.4 | 1.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.4 | 3.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.4 | 1.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.4 | 2.5 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.4 | 1.7 | GO:0035473 | lipase binding(GO:0035473) |
| 0.4 | 4.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.4 | 7.7 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.4 | 3.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.4 | 3.2 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
| 0.4 | 2.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.4 | 3.5 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.4 | 26.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.4 | 1.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.4 | 3.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.4 | 8.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.4 | 0.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.4 | 3.5 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.4 | 5.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.4 | 1.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.4 | 1.1 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
| 0.4 | 0.4 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.4 | 0.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.4 | 5.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.4 | 3.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.4 | 2.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.4 | 8.0 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.4 | 3.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.4 | 6.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.4 | 1.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.4 | 2.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.4 | 7.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.4 | 4.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.4 | 6.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.3 | 1.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.3 | 8.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.3 | 1.0 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
| 0.3 | 2.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.3 | 3.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 4.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.3 | 1.4 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
| 0.3 | 6.2 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.3 | 1.7 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.3 | 1.4 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.3 | 11.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.3 | 15.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.3 | 7.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 27.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.3 | 1.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.3 | 13.0 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.3 | 24.3 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
| 0.3 | 3.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.3 | 0.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.3 | 0.3 | GO:0097617 | annealing activity(GO:0097617) |
| 0.3 | 1.0 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.3 | 3.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.3 | 11.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.3 | 20.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.3 | 1.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.3 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 41.4 | GO:0042393 | histone binding(GO:0042393) |
| 0.3 | 39.3 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.3 | 1.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.3 | 1.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.3 | 0.6 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.3 | 1.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.3 | 9.6 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.3 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.3 | 2.4 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.3 | 1.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.3 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.3 | 0.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.3 | 0.6 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
| 0.3 | 0.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.3 | 0.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.3 | 2.3 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.3 | 1.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.3 | 9.0 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 0.3 | 3.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.3 | 0.6 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.3 | 2.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.3 | 1.4 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.3 | 3.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.3 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
| 0.3 | 2.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.3 | 0.8 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.3 | 0.3 | GO:0034595 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
| 0.3 | 10.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.3 | 2.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.3 | 9.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.3 | 0.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.3 | 0.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.3 | 0.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.3 | 1.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.3 | 9.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.3 | 4.0 | GO:0042805 | actinin binding(GO:0042805) |
| 0.3 | 1.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.3 | 1.1 | GO:0070976 | TIR domain binding(GO:0070976) |
| 0.3 | 2.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.3 | 0.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.3 | 0.8 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
| 0.3 | 1.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.3 | 1.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.3 | 3.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.2 | 0.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.2 | 1.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.2 | 1.7 | GO:0070061 | fructose binding(GO:0070061) |
| 0.2 | 7.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.2 | 0.7 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.2 | 5.6 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 0.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.2 | 0.9 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.2 | 1.4 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.2 | 3.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 23.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.2 | 6.1 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
| 0.2 | 3.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.2 | 0.9 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.2 | 1.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.2 | 3.0 | GO:0001067 | regulatory region DNA binding(GO:0000975) regulatory region nucleic acid binding(GO:0001067) transcription regulatory region DNA binding(GO:0044212) |
| 0.2 | 0.6 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
| 0.2 | 3.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 1.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.2 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.2 | 1.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.2 | 1.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.2 | 0.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.2 | 1.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.2 | 1.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.2 | 1.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.2 | 2.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.2 | 3.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.2 | 4.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.2 | 1.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.2 | 1.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.2 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.2 | 27.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.2 | 3.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.2 | 19.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.2 | 0.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.2 | 2.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
| 0.2 | 5.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.2 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.2 | 2.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.2 | 3.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.2 | 2.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.2 | 1.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.2 | 1.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.2 | 1.0 | GO:0009374 | biotin binding(GO:0009374) |
| 0.2 | 2.3 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
| 0.2 | 0.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.2 | 3.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 5.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.2 | 1.0 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.2 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.2 | 0.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.2 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.2 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 1.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.2 | 0.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.2 | 2.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.2 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.2 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.1 | 12.8 | GO:0003712 | transcription cofactor activity(GO:0003712) |
| 0.1 | 0.6 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
| 0.1 | 0.4 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.1 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 1.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 5.9 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
| 0.1 | 3.2 | GO:0004620 | phospholipase activity(GO:0004620) |
| 0.1 | 57.0 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 1.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
| 0.1 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 0.5 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
| 0.1 | 0.4 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
| 0.1 | 0.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.1 | 0.6 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.1 | 3.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 0.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.1 | 1.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 4.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 0.3 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.1 | 1.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 1.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.1 | 1.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.1 | 0.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.1 | 0.6 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.1 | 1.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.1 | 1.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 0.3 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
| 0.1 | 1.1 | GO:0070513 | death domain binding(GO:0070513) |
| 0.1 | 2.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 12.1 | GO:0008134 | transcription factor binding(GO:0008134) |
| 0.1 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 0.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.1 | 0.3 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.1 | 0.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.1 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 0.8 | GO:0004601 | peroxidase activity(GO:0004601) |
| 0.1 | 2.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.1 | 7.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 0.7 | GO:0019840 | isoprenoid binding(GO:0019840) |
| 0.1 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 1.5 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.1 | 0.4 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 0.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.1 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 0.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 2.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 1.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.1 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
| 0.1 | 0.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 26.7 | GO:0003677 | DNA binding(GO:0003677) |
| 0.1 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
| 0.1 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 4.1 | GO:0015103 | inorganic anion transmembrane transporter activity(GO:0015103) |
| 0.0 | 0.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 1.2 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
| 0.0 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
| 0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.0 | 0.1 | GO:0004454 | ketohexokinase activity(GO:0004454) |
| 0.0 | 0.4 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
| 0.0 | 1.0 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 0.0 | 0.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.0 | 0.5 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
| 0.0 | 0.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.0 | 0.4 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.0 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.0 | 1.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
| 0.0 | 4.0 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
| 0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.0 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.0 | 0.0 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 0.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.0 | 0.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 181.5 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 2.4 | 9.5 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 2.3 | 2.3 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
| 2.1 | 82.8 | PID_AURORA_B_PATHWAY | Aurora B signaling |
| 1.9 | 57.7 | PID_AURORA_A_PATHWAY | Aurora A signaling |
| 1.7 | 66.2 | PID_ATR_PATHWAY | ATR signaling pathway |
| 1.6 | 4.7 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
| 1.5 | 45.1 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
| 1.4 | 40.7 | PID_MYC_PATHWAY | C-MYC pathway |
| 1.2 | 3.6 | ST_ADRENERGIC | Adrenergic Pathway |
| 1.2 | 77.6 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
| 1.0 | 9.4 | PID_IL5_PATHWAY | IL5-mediated signaling events |
| 1.0 | 22.8 | PID_IL23_PATHWAY | IL23-mediated signaling events |
| 1.0 | 47.7 | PID_IGF1_PATHWAY | IGF1 pathway |
| 1.0 | 7.9 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.9 | 49.3 | PID_THROMBIN_PAR1_PATHWAY | PAR1-mediated thrombin signaling events |
| 0.9 | 4.7 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.9 | 18.6 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.8 | 5.1 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
| 0.8 | 2.5 | PID_IL8_CXCR1_PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.8 | 19.2 | PID_HEDGEHOG_GLI_PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.8 | 1.6 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.8 | 20.2 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
| 0.8 | 9.1 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.7 | 5.1 | PID_IL1_PATHWAY | IL1-mediated signaling events |
| 0.7 | 24.1 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.7 | 15.5 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.7 | 28.2 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
| 0.7 | 36.5 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
| 0.7 | 1.3 | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.7 | 11.2 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.6 | 8.3 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.6 | 10.3 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.6 | 21.0 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
| 0.6 | 16.6 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
| 0.6 | 33.9 | PID_E2F_PATHWAY | E2F transcription factor network |
| 0.5 | 1.1 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.5 | 14.6 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.5 | 16.0 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.5 | 23.2 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.5 | 18.3 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.5 | 12.2 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.4 | 3.1 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.4 | 3.4 | NABA_COLLAGENS | Genes encoding collagen proteins |
| 0.4 | 4.2 | PID_BARD1_PATHWAY | BARD1 signaling events |
| 0.4 | 26.8 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
| 0.4 | 19.2 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.4 | 8.2 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.4 | 12.7 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.4 | 1.1 | PID_IL3_PATHWAY | IL3-mediated signaling events |
| 0.3 | 11.9 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
| 0.3 | 6.3 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.3 | 9.1 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.3 | 3.5 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.3 | 3.8 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.3 | 13.9 | ST_FAS_SIGNALING_PATHWAY | Fas Signaling Pathway |
| 0.3 | 10.2 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.3 | 7.3 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.3 | 9.5 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
| 0.3 | 20.2 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.3 | 4.1 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.3 | 7.6 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.3 | 7.5 | PID_ECADHERIN_STABILIZATION_PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.3 | 2.6 | ST_B_CELL_ANTIGEN_RECEPTOR | B Cell Antigen Receptor |
| 0.3 | 1.5 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.3 | 8.9 | PID_CXCR4_PATHWAY | CXCR4-mediated signaling events |
| 0.2 | 4.5 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.2 | 2.5 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
| 0.2 | 1.0 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.2 | 7.5 | PID_BMP_PATHWAY | BMP receptor signaling |
| 0.2 | 2.0 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 2.0 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
| 0.2 | 2.2 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.2 | 5.7 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
| 0.2 | 1.5 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 1.8 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.2 | 1.0 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 2.1 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 0.7 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 1.4 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 1.2 | PID_IL6_7_PATHWAY | IL6-mediated signaling events |
| 0.1 | 0.5 | PID_ALK2_PATHWAY | ALK2 signaling events |
| 0.1 | 2.4 | PID_INTEGRIN1_PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 1.9 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 3.4 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
| 0.1 | 1.4 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 2.1 | PID_FGF_PATHWAY | FGF signaling pathway |
| 0.1 | 0.9 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
| 0.1 | 1.0 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
| 0.1 | 4.9 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
| 0.1 | 1.7 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
| 0.1 | 0.2 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.1 | 2.5 | PID_P73PATHWAY | p73 transcription factor network |
| 0.1 | 0.4 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 0.8 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 0.8 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
| 0.1 | 1.4 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.1 | 0.6 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 1.8 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.3 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.4 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
| 0.0 | 0.2 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
| 0.0 | 0.2 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 3.5 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.1 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.1 | ST_INTERFERON_GAMMA_PATHWAY | Interferon gamma pathway. |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.2 | 113.4 | REACTOME_KINESINS | Genes involved in Kinesins |
| 3.6 | 3.6 | REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 3.4 | 6.9 | REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 3.1 | 49.3 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
| 2.7 | 10.9 | REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 2.7 | 62.5 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 2.5 | 30.0 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 2.5 | 47.2 | REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 2.3 | 18.8 | REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 2.3 | 48.3 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
| 2.3 | 2.3 | REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 2.2 | 31.5 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 2.2 | 31.1 | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 2.0 | 4.0 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 1.9 | 3.9 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 1.9 | 44.4 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 1.8 | 3.6 | REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 1.8 | 12.5 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 1.8 | 33.8 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 1.7 | 18.8 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 1.7 | 27.2 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 1.6 | 17.4 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
| 1.6 | 7.8 | REACTOME_PACKAGING_OF_TELOMERE_ENDS | Genes involved in Packaging Of Telomere Ends |
| 1.5 | 10.8 | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 1.5 | 80.1 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 1.5 | 6.0 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
| 1.5 | 17.5 | REACTOME_LAGGING_STRAND_SYNTHESIS | Genes involved in Lagging Strand Synthesis |
| 1.4 | 79.3 | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 1.4 | 14.2 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 1.4 | 15.6 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
| 1.4 | 18.3 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
| 1.4 | 16.7 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 1.4 | 42.8 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 1.4 | 11.0 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 1.4 | 37.1 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 1.3 | 22.8 | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 1.3 | 12.1 | REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 1.3 | 19.8 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 1.3 | 70.9 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 1.3 | 14.4 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 1.3 | 40.9 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
| 1.2 | 29.2 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 1.2 | 8.1 | REACTOME_G2_M_CHECKPOINTS | Genes involved in G2/M Checkpoints |
| 1.1 | 2.3 | REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 1.1 | 23.5 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
| 1.1 | 22.1 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 1.1 | 4.4 | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 1.1 | 3.2 | REACTOME_SIGNAL_AMPLIFICATION | Genes involved in Signal amplification |
| 1.1 | 1.1 | REACTOME_PI3K_AKT_ACTIVATION | Genes involved in PI3K/AKT activation |
| 1.0 | 10.5 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 1.0 | 6.1 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 1.0 | 2.0 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 1.0 | 5.8 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.9 | 5.5 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.9 | 5.5 | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.9 | 19.1 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.9 | 60.5 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
| 0.9 | 7.1 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.9 | 22.9 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.9 | 7.8 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
| 0.8 | 64.8 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.8 | 16.4 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.8 | 6.0 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.7 | 8.9 | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.7 | 4.2 | REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.7 | 11.7 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.7 | 4.6 | REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.6 | 14.9 | REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.6 | 5.7 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.6 | 14.0 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.6 | 7.6 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.6 | 2.4 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.6 | 17.9 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
| 0.6 | 6.1 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.5 | 10.4 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.5 | 6.0 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.5 | 63.0 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
| 0.5 | 7.3 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.5 | 9.7 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.5 | 2.5 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.5 | 3.5 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.5 | 6.9 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.5 | 2.0 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.5 | 15.7 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.5 | 7.3 | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.5 | 3.4 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.5 | 49.1 | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.5 | 6.7 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.5 | 83.5 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.5 | 9.4 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.4 | 12.2 | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.4 | 9.6 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
| 0.4 | 6.6 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.4 | 5.7 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
| 0.4 | 4.0 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.4 | 5.5 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.4 | 12.1 | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.4 | 1.6 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.4 | 4.3 | REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.4 | 33.0 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.4 | 4.1 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
| 0.4 | 3.2 | REACTOME_GLOBAL_GENOMIC_NER_GG_NER | Genes involved in Global Genomic NER (GG-NER) |
| 0.3 | 7.0 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.3 | 1.0 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.3 | 1.3 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.3 | 2.5 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.3 | 0.3 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.3 | 22.6 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.3 | 8.6 | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 0.3 | 2.0 | REACTOME_TELOMERE_MAINTENANCE | Genes involved in Telomere Maintenance |
| 0.3 | 5.2 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
| 0.3 | 6.2 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
| 0.3 | 0.8 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.2 | 6.8 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.2 | 13.4 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.2 | 0.4 | REACTOME_BASE_EXCISION_REPAIR | Genes involved in Base Excision Repair |
| 0.2 | 1.9 | REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.2 | 8.8 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.2 | 1.2 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 12.6 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 23.4 | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.2 | 1.7 | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.2 | 2.7 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
| 0.2 | 1.5 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.2 | 2.8 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.2 | 6.3 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.2 | 1.6 | REACTOME_SIGNALING_BY_FGFR3_MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.2 | 0.7 | REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.2 | 1.8 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.2 | 7.4 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.2 | 1.4 | REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.2 | 7.4 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.2 | 3.7 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.2 | 1.5 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.2 | 2.0 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 0.6 | REACTOME_RNA_POL_I_TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.1 | 1.7 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 1.6 | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 4.9 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.1 | 1.2 | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 0.8 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 3.8 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 0.8 | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.1 | 1.1 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 2.1 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 0.7 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.1 | 0.8 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.1 | 1.0 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 3.9 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
| 0.1 | 1.2 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
| 0.1 | 0.6 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
| 0.1 | 4.9 | REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.1 | 3.5 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 0.2 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 1.7 | REACTOME_SPHINGOLIPID_METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.1 | 2.2 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 0.5 | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 2.4 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 0.9 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
| 0.1 | 0.3 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.1 | 1.1 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 0.2 | REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.0 | 0.9 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 0.4 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.0 | 0.4 | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| 0.0 | 0.6 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.0 | 0.2 | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 0.2 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 2.6 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.0 | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | Genes involved in Bile acid and bile salt metabolism |
| 0.0 | 0.1 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
|
|
|